Stay updated with breaking news from Single Use Instruments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WALTHAM, Mass., May 01, 2023 (GLOBE NEWSWIRE) -- BVI, a diversified global ophthalmic device company, today announced it has completed enrollment of its U.S. Investigational Device Exemption (IDE) clinical
(1) First of a planned family of TORIC IOLs offered on BVI's proprietary G-Free hydrophobic material Features the unique Double C-loop haptic platform - specifically designed for improved stability required by TORIC IOLs for long-term, accurate astigmatism correction Of 3,649 papers reviewed, 31 studies from 32 publications met the inclusion criteria of this review. Preexisting astigmatism ≥1D was present in up to 47% of cataract eyes. 1 WALTHAM, MA / ACCESSWIRE / February 2, 2021 / BVI, the most dynamic, diversified company in ophthalmology, announces today the commercial launch of our POD...